approach to tachyarrhythmias

in review 8 min read Updated 2026-11-09
approach to tachyarrhythmias

Unstable → synchronised cardioversion, whatever the rhythm. Stable → 12-lead ECG during tachycardia, then sort by QRS width and regularity. Regular narrow → vagal manoeuvre → adenosine 6 → 12 → 18 mg (terminates AVNRT/AVRT; unmasks flutter/AT). Wide and uncertain → treat as VT; never verapamil/diltiazem. Irregular, very fast, bizarre wide complexes → pre-excited AF → procainamide or ibutilide, no AV-nodal blockers.

do not miss
  • Pre-excited AF — AV-nodal blockers (adenosine, verapamil, diltiazem, beta-blocker, digoxin, IV amiodarone) can precipitate VF
  • VT mislabelled as SVT with aberrancy — wide complex + structural heart disease = VT until proven otherwise
  • Sinus tachycardia from sepsis, bleeding, PE, hypoxia — treat the cause, not the rate
pre-excited AF (WPW)

Irregular, very fast, varying wide QRS. Unstable → synchronised cardioversion.

first
then / if needed
  • DCCV if it persists; refer to ablate the pathway
avoid
  • AV-nodal blockers — adenosine, verapamil, diltiazem, beta-blocker, digoxin
  • IV amiodarone — enhances pathway conduction → VF

mechanism → management

  • AV node in the circuit (AVNRT, orthodromic AVRT) → anything that transiently blocks the node (vagal, adenosine, CCB, BB) terminates it
  • AV node as bystander (flutter, atrial tachycardia, AF) → nodal block only slows the ventricle and unmasks the atrial rhythm — diagnostic, not curative
  • Accessory pathway has no decremental conduction → AF conducts down it at >250/min; blocking the node shifts more conduction to the pathway → VF
  • CCB in VT → vasodilation + negative inotropy on a ventricle already failing → collapse
  • Adenosine acts via A1 receptors on the AV node (AH interval), half-life seconds → rapid proximal bolus + flush; can trigger AF (more often with AVRT) and accelerate pre-excited rhythms

algorithm

graph TD
    A[Tachycardia] --> B{Unstable?<br/>hypotension, ischaemia, AMS, HF}
    B -->|yes| C[Synchronised DC cardioversion]
    B -->|no| D[12-lead ECG during tachycardia]
    D --> E{QRS ≥120 ms?}
    E -->|no, regular| F[Vagal manoeuvre → adenosine 6–12–18 mg<br/>then IV verapamil/diltiazem or beta-blocker]
    E -->|no, irregular| G[AF, flutter with variable block, multifocal AT<br/>→ rate control]
    E -->|yes, regular| H[Presume VT<br/>adenosine only if no pre-excitation on resting ECG<br/>DCCV or IV procainamide; amiodarone second line]
    E -->|yes, irregular| I{Very fast, varying bizarre QRS?}
    I -->|yes| J[Pre-excited AF<br/>procainamide or ibutilide; DCCV<br/>NO AV-nodal blockers]
    I -->|no| K[AF with aberrancy, or polymorphic VT<br/>check QT]

narrow complex tachycardia (QRS <120 ms)

RhythmRegular?Clues
sinus tachycardiayesgradual onset/offset, normal P before each QRS; look for the driver
AVNRTyesabrupt onset; P buried in QRS or pseudo-r′ in V1
orthodromic AVRTyesabrupt onset; retrograde P in ST segment; pre-excitation in sinus rhythm (WPW) or concealed pathway
atrial flutteryes (fixed block)rate ~150 with 2:1; sawtooth inferior leads, unmasked by adenosine
focal ATyes or variableabnormal P morphology, warm-up
AF / MATnono organised P (AF); ≥3 P morphologies (MAT, lung disease)

acute treatment (stable)

  1. Vagal manoeuvres supine with legs raised — modified Valsalva (strain semi-recumbent — blow into a 10 mL syringe hard enough to move the plunger — then lie flat with passive leg raise) ~43% vs 17% conversion. Carotid massage: unilateral, ≤5 s, not with bruit or prior stroke/TIA
  2. Adenosine 6 mg rapid IV bolus via antecubital vein + immediate flush → 12 mg → consider 18 mg; repeat safe within 1 min. Warn of flushing, chest pain, dyspnoea. Caution with known sinus node disease; severe asthma → verapamil preferred
  3. Verapamil 0.075–0.15 mg/kg (5–10 mg) over 2 min or diltiazem 0.25 mg/kg (~20 mg) over 2 min — avoid if hypotension, LVEF <40%, suspected VT or pre-excited AF
  4. Beta-blocker (esmolol, metoprolol) — avoid in decompensated HF
  5. Synchronised DCCV if drugs fail or are contraindicated, even when stable (I)
Response to adenosineMeaning
terminatesAVNRT or AVRT (node in circuit)
transient AV block revealing flutter waves / P wavesflutter or atrial tachycardia (node is bystander)
gradual slowing, then re-accelerationsinus tachycardia or automatic AT
no effectinadequate dose/delivery, or high septal VT

long-term

  • Recurrent symptomatic AVNRT or AVRT → catheter ablation first-line (I; high cure rate, low complication rate)
  • Drugs if ablation declined: beta-blocker, diltiazem/verapamil (not with manifest pre-excitation), flecainide/propafenone if no structural heart disease → antiarrhythmics
  • Typical flutter: anticoagulate as AF; CTI ablation for recurrent symptomatic flutter (I). Cardioversion: low-energy DCCV (≤100 J biphasic) or ibutilide (I); no flecainide/propafenone (III) → atrial fibrillation

wide complex tachycardia (QRS ≥120 ms)

Default = VT, especially with prior MI or cardiomyopathy. Haemodynamic stability does not exclude VT.

Favours VTFinding
AV dissociationventricular rate > atrial rate (dissociated P waves) — most specific
fusion / capture beatsintermittent normal-looking or hybrid complexes
negative precordial concordanceall V1–V6 predominantly negative
no RS complex in any precordial lead, or R-to-S nadir >100 msBrugada criteria
aVRinitial R wave, or initial r/q >40 ms (Vereckei)
extreme (northwest) axis−90° to ±180°
lead II R-wave peak time ≥50 ms
RBBB-likeV1 monophasic R, qR, or taller left “rabbit ear”; V6 R:S <1
LBBB-likeV1 broad R >40 ms, slurred/notched S downstroke; V6 Q or QS
  • Other causes of wide-complex regular tachycardia: SVT with pre-existing or rate-related BBB, antidromic AVRT, paced rhythm, hyperkalaemia or Na⁺-channel blocker toxicity
  • Stable WCT: DCCV or procainamide IV (IIa; CCS first line for stable VT with structural disease), amiodarone IV second line (IIb); adenosine only if no pre-excitation on a prior ECG (diagnostic for SVT with aberrancy); verapamil contraindicated
  • Confirmed VT management → ventricular arrhythmias and sudden cardiac death

pre-excitation and WPW

  • Accessory pathway: myocardial AV connection outside the node, conducts without nodal delay → ventricle activates early
  • WPW pattern (ECG in sinus rhythm): PR <120 ms, delta wave, QRS ≥120 ms. Fusion beat — pathway starts the QRS, His-Purkinje finishes it, so the terminal QRS is normal. Prevalence 0.13–0.25%; can come and go or disappear
  • WPW syndrome: pattern + AVRT, pre-excited AF/flutter or cardiac arrest. Usually presumed from a tachycardia with pre-excitation on a prior or post-conversion ECG; EPS confirms the pathway is involved
  • Normal sinus ECG does not exclude a pathway: pre-excitation can be intermittent; concealed pathways conduct retrograde only → orthodromic AVRT, no delta wave
  • Mimics of the pattern: MI (negative delta reads as Q wave — posteroseptal pathways give inferior “Q waves”; positive delta can hide a true infarct), BBB (WPW: abnormal start, normal end of QRS), ventricular bigeminy if alternate beats pre-excite, HCM (short PR, wide QRS; true pathways can coexist)
  • Echo if structural disease suspected (HCM, Ebstein) and in athletes or safety-critical jobs
ScenarioManagement
pre-excited AF (irregular, very fast, varying wide QRS)unstable → DCCV. Stable → procainamide or ibutilide (I, ACC/AHA), though CCS notes DCCV may be preferred as the drug evidence is thin; flecainide/propafenone with caution if no structural disease (ESC). IV amiodarone not recommended (III — enhanced pathway conduction, VF). No CCB, BB, digoxin (III; oral digoxin harmful long term too); no adenosine (contraindicated, UpToDate). Then ablate the pathway
pre-excited flutter (regular, wide, often >250/min)looks like VT; manage as pre-excited AF
orthodromic AVRT (narrow; >90% of AVRT)down node, up pathway; retrograde P with short RP. Vagal → adenosine (have defibrillator ready — may trigger AF) → ablation
antidromic AVRT (wide)down pathway, up node; QRS matches pre-excited sinus beats. Treat as WCT: procainamide/ibutilide, DCCV; ablation. No CCB or BB (VF risk); avoid adenosine if pre-excited on resting ECG (can induce AF → arrest)
PJRT (narrow, long RP, incessant)slow concealed pathway; tachycardia cardiomyopathy. Hard to suppress with drugs → ablation

risk-stratifying the incidental pattern

About 1 in 5 asymptomatic patients develop an arrhythmia; SCD as the first event is rare and risk falls with age. The target is a pathway that can conduct AF fast enough to cause VF.

  • Non-invasive (exercise test, Holter): intermittent pre-excitation or abrupt loss of pre-excitation on exercise = low-risk markers (I, ACC/AHA). Not a guarantee — about a fifth with intermittent pre-excitation still have pathway ERP <250 ms. Persistent pre-excitation does not mean high risk, it only fails to show low risk
  • EPS with isoprenaline if high-risk occupation (pilot, professional driver), competitive athlete or not clearly low risk
  • High risk → ablate: SPERRI or pathway ERP ≤250 ms (UpToDate uses ERP ≤240 ms), multiple pathways or inducible AVRT
  • Guidelines differ on the rest: ESC favours EPS (IIa; non-invasive IIb), ACC/AHA accepts EPS or observation alone (both IIa). Sensible default: exercise test first, EPS if pre-excitation persists and ablation would be accepted; observation is reasonable in older adults
  • Symptomatic = syndrome → stratification does not change the decision, refer for ablation (>90% acute success; complications 1.5–3%, AV block needing pacing 0.3–1%). Short pathway ERP, arrhythmic syncope, multiple pathways or AVRT degenerating to pre-excited AF → urgent (CCS)

sinus tachycardia

  • Physiological in most → look for fever, sepsis, hypovolaemia, bleeding, PE, hypoxia, pain, anaemia, hyperthyroidism, drugs/withdrawal
  • Inappropriate sinus tachycardia: resting HR >100, mean >90/24 h, no cause → exclude reversible causes first; ivabradine ± beta-blocker for symptoms (IIa, ESC); beta-blockers alone often ineffective
  • POTS → postural orthostatic tachycardia syndrome

Prepared 2026-11-09. Not yet verified — check every number against the sources.

Key references

+7 more sources

Suggest a correction approach to tachyarrhythmias